These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10803731)

  • 21. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN; Florijn KW; Muizert Y; Chang PC
    Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans.
    Goldstein DS; Stull R; Eisenhofer G; Gill JR
    Clin Sci (Lond); 1989 May; 76(5):517-22. PubMed ID: 2498027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing dopaminergic activity through different pathways: consequences for renal sodium excretion, regional blood flow and oxygen tension in the rat.
    Odlind C; Fasching A; Liss P; Palm F; Hansell P
    Acta Physiol Scand; 2001 Jul; 172(3):219-26. PubMed ID: 11472309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuated renal production of dopamine in patients with low renin essential hypertension.
    Aoki K; Kikuchi K; Yamaji I; Nishimura M; Honma C; Kobayakawa H; Yamamoto M; Kudoh C; Shimazaki M; Sakamoto T
    Clin Exp Hypertens A; 1989; 11 Suppl 1():403-9. PubMed ID: 2663252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blunted renal dopaminergic system activity in HgCl2-induced membranous nephropathy.
    Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
    Life Sci; 2006 Feb; 78(11):1246-55. PubMed ID: 16182313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between sodium balance, intrarenal dopamine synthesis, and sympathetic activity in HLA-identical kidney donors and recipients.
    Barendregt JN; van Nispen tot Pannerden LL; Chang PC
    Nephrol Dial Transplant; 1995; 10(3):341-8. PubMed ID: 7792028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial acute effects of selective modulation of renal dopamine system by gamma-L-glutamyl-L-dopa in rabbits with congestive heart failure.
    Wang ZQ; Way D; Shimizu K; Fong F; Trigg L; McGrath BP
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):1004-11. PubMed ID: 7687706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension.
    Gill JR; Grossman E; Goldstein DS
    Hypertension; 1991 Nov; 18(5):614-21. PubMed ID: 1937664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic fructose overload on renal dopaminergic system: alteration of urinary L-dopa/dopamine index correlates to hypertension and precedes kidney structural damage.
    Rukavina Mikusic NL; Kouyoumdzian NM; Del Mauro JS; Cao G; Trida V; Gironacci MM; Puyó AM; Toblli JE; Fernández BE; Choi MR
    J Nutr Biochem; 2018 Jan; 51():47-55. PubMed ID: 29091814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the nature of the antagonistic actions of dopamine and 5-hydroxytryptamine in renal tissues.
    Soares-da-Silva P; Vieira-Coelho MA; Pinto-do-O PC; Pestana M; Bertorello AM
    Hypertens Res; 1995 Jun; 18 Suppl 1():S47-51. PubMed ID: 8529074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
    Shigetomi S; Kuchel O
    Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
    Kuchel OG; Shigetomi S
    Hypertension; 1994 Jan; 23(1 Suppl):I240-5. PubMed ID: 8282367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium-dependence and ouabain-sensitivity of the synthesis of dopamine in renal tissues of the rat.
    Soares-da-Silva P; Fernandes MH
    Br J Pharmacol; 1992 Apr; 105(4):811-6. PubMed ID: 1504714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation.
    Venkatakrishnan U; Chen C; Lokhandwala MF
    Clin Exp Hypertens; 2000 Apr; 22(3):309-24. PubMed ID: 10803736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate.
    de Toledo FG; Thompson MA; Bolliger C; Tyce GM; Dousa TP
    Kidney Int; 1999 May; 55(5):1832-42. PubMed ID: 10231445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal dopaminergic system in nephrotic syndrome and after remission.
    Pestana M; Jardim H; Afonso C; Serrão P; Santos N; Guerra L; Soares-da-Silva P
    Nephrol Dial Transplant; 1998 Oct; 13(10):2559-62. PubMed ID: 9794559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of renal dopamine on pathogenesis of essential hypertension].
    Kohno H
    Nihon Jinzo Gakkai Shi; 1991 Mar; 33(3):311-9. PubMed ID: 2062017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of dopamine-induced natriuresisby the dopamine-metabolizing enzyme catechol-O-methyltransferase.
    Odlind C; Göransson V; Reenilä I; Hansell P
    Exp Nephrol; 1999; 7(4):314-22. PubMed ID: 10450019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outflow of dopamine and noradrenaline originating from L-dopa and L-threo-DOPS in rat renal tissues.
    Pestana M; Soares-Da-Silva P
    Gen Pharmacol; 1994 Sep; 25(5):879-85. PubMed ID: 7835631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of renal interstitial infusion of L-dopa on sodium and phosphate excretions.
    LeClaire MM; Berndt TJ; Knox FG
    J Lab Clin Med; 1998 Oct; 132(4):308-12. PubMed ID: 9794702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.